Pediatrix Medical Group, Inc.MDNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +1.19% | -7.42% | -7.03% | -3.58% | -1.71% |
| Gross Profit Growth | +27.04% | +8.18% | +9.30% | +20.14% | -6.36% |
| EBITDA Growth | +0.00% | +48.19% | +0.00% | +131.62% | +20.15% |
| Operating Income Growth | +0.00% | +101.99% | +0.00% | +101.17% | +39.15% |
| Net Income Growth | +0.00% | +413.93% | +0.00% | +268.85% | +10.51% |
| EPS Growth | +0.00% | +380.00% | +0.00% | +269.57% | +14.29% |
| EPS Diluted Growth | +0.00% | +380.00% | +0.00% | +265.22% | +14.29% |
| Weighted Average Shares Growth | +2.20% | +3.56% | +4.23% | +1.76% | -1.69% |
| Weighted Average Shares Diluted Growth | +2.20% | +3.04% | +4.23% | +1.29% | -1.69% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +92.07% | +0.00% | +28.25% | +49.49% | -14.22% |
| Free Cash Flow Growth | +115.21% | +0.00% | +32.67% | +54.24% | -16.02% |
| Receivables Growth | -2.60% | -12.51% | -10.05% | -19.78% | -11.11% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -3.02% | -8.06% | +5.35% | +5.90% | +4.37% |
| Book Value per Share Growth | -11.85% | -10.99% | +13.23% | +19.49% | +15.14% |
| Debt Growth | -5.61% | -15.84% | -6.98% | -6.05% | -0.30% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +19.77% | -2.65% | -1.50% | +4.60% | +3.35% |